febrero 2007 - DERMAGIC EXPRESS / Dermatologia y Bibliografia - Dermatology & bibliography DERMAGIC EXPRESS / Dermatologia y Bibliografia - Dermatology & bibliography: febrero 2007

domingo, 25 de febrero de 2007

ELIDEL Y PROTOPIC EFECTOS ADVERSOS / ELIDEL AND PROTOPIC ADVERSE EFFECTS

 

ELIDEL (Pimecrolimus) y PROTOPIC (Tacrolimus) EFECTOS SECUNDARIOS !!!


            ELIDEL (Pimecrolimus) and PROTOPIC  (Tacrolimus) ADVERSE EFFECTS !!!            



Tacrolimus y Pimecrolimus asociados a cancer




PUBLICADO 2007 ACTUALIZADO 2023



EDITORIAL ESPANOL
=================

Las Cremas Elidel (Pimecrolimus) y Protopic (tacrolimus) fueron lanzadas al mercado para tratar el eczema y dermatitis Atópica, aprobadas por la FDA en el año 2.000 y 2001.

Creo nadie pensó que iban a estar asociadas a riesgo de contraer cáncer. Esta perla es del  año 2.005 en que se hicieron los primeros reportes, el mismo año en que el Dermagic cancelo sus publicaciones.

A petición de numerosos pacientes el Dermagic esta de regreso y una vez mas con estas 7 referencias, queda demostrado apocalipticamente y contundentemente lo que esta ocurriendo con estas cremas y la excelencia del Dermagic.

....La FDA ha recibido los informes de 78 casos de cáncer, incluso piel y linfoma, en pacientes tratados con  Elidel o Protopic.....

Estas cremas nacieron como grandes promesas y adelantos en el tratamiento de la dermatitis atópica, pero el tiempo se encargo de demostrar que su uso prolongado puede inducir la aparición de varios tipos de cáncer

"Elidel (pimecrolimus) y Protopic (tacrolimus) son medicamentos inmunosupresores que se utilizan para tratar ciertas afecciones de la piel. Debido a su acción inmunosupresora, estos medicamentos pueden favorecer el desarrollo de tumores si se absorben en cantidades suficientes a través de la piel y si el tratamiento se mantiene durante tiempos prolongados."

Saludos.


Dr. José Lapenta

EDITORIAL ENGLISH
================

The Creams Elidel (Pimecrolimus) and Protopic (tacrolimus) they were thrown to the market to treat the eczema and  Atopic dermatitis, approved by the FDA in the year 2.000 and 2001

I believe nobody  thought that they will be associated to risk of contracting cancer. This pearl is from the year 2.005 when that the first reports were made, the same year  that the Dermagic cancels their publications.

At the request of numerous patients the Dermagic is BACK and once,  with these 7 references, it is demonstrated apocalyptically and overwhelmingly what is this happening with these creams and the excellence of the Dermagic. 

......the FDA has received reports of 78 cases of cancers, including skin and lymphoma, in patients treated with both Elidel or Protopic.....

These creams were born as great promises and advances in the treatment of atopic dermatitis, but time took care of demonstrating that their prolonged use can induce the appearance of various types of cancer.


"Elidel (pimecrolimus) and Protopic (tacrolimus) are immunosuppressive drugs used to treat certain skin conditions. Due to their immunosuppressive action, these drugs may promote tumor development if sufficient amounts are absorbed through the skin and if the treatment is maintained for long periods of time."


Greetings

Dr. Jose Lapenta R.

=====================================================
REFERENCIAS BIBLIOGRAFICAS / BIBLIOGRAPHICAL REFERENCES
====================================================
1.) Protopic and Elidel may cause cancer
====================================================

2.) Protopic Causing Cancer
===================================================

3.) PROTOPIC, side effects
====================================================
4.) Alert for Healthcare Professionals Pimecrolimus (marketed as Elidel)
=====================================================
5.) Injured by Elidel?
=====================================================
6.) Pimecrolimus tópico (Elidel) Español/Spanish
===================================================

7.) Cancer warning over eczema creams (Elidel and Protopic)
=====================================================
 
=================================================

1.) Protopic and Elidel may cause cancer
====================================================

Source: Http://www.news.medical-net.

Protopic and Elidel may cause cancer
Pharmaceutical News
Published: Sunday, 13-Mar-2005


Protopic and Elidel, two treatments for eczema approved in 2000 and 2001, have now been found to cause cancer in three different animal species.
The Food and Drug Administration (FDA) has advised health care professionals to prescribe Elidel (pimecrominum) and Protopic (tacrolimus) only as directed and only after other eczema treatments have failed to work because this potential cancer risk associated with their use. It is also adding a black box warning to the health professional label for the products and developing a Medication Guide for patients.

The actions follow the recommendations made by the FDA's Pediatric Advisory Committee during its meeting last month (Feb 2005). Cancer was found in animal species and data showed that the risk of cancer increased as the amount of the drug given increased.

The data also included a small number of reports of cancers in children and adults treated with Elidel or Protopic.The manufacturers of the products will conduct research to determine whether there is an actual risk of cancer in humans, and, if so, its extent. Both products are applied to the skin to control eczema, but do so by suppressing the immune system.

FDA's Public Health Advisory specifically advises physicians to weigh the risks and benefits of these drugs in adults and children and consider the following:

Elidel and Protopic are approved for short-term and intermittent treatment of atopic dermatitis (eczema) in patients unresponsive to, or intolerant of other treatments.
Elidel and Protopic are not approved for use in children younger than 2 years old. The long-term effect of Elidel and Protopic on the developing immune system in infants and children is not known. In clinical trials, infants and children younger than 2 years of age treated with Elidel had a higher rate of upper respiratory infections than those treated with placebo cream.
Elidel and Protopic should be used only for short periods of time, not continuously. The long term safety of these products is unknown.
Children and adults with a weakened or compromised immune system should not use Elidel or Protopic.
Use the minimum amount of Elidel and Protopic needed to control the patient's symptoms. The animal data suggest that the risk of cancer increases with increased exposure to Elidel or Protopic.

http://www.fda.gov

==================================================
2.) Protopic Causing Cancer
===================================================

Source: http://www.onlinelawyersource.com/

The FDA’s public health advisory announcement about Protopic causing cancer came in March 2005 after researchers discovered that patients using this prescription ointment are at an increased risk of developing lymph node and skin cancer. As a result of Protopic causing cancer, the FDA has warned doctors and patients of these risks and advised them to only use Protopic when alternative treatments have failed or cannot be tolerated.

Protopic is a topical tacrolimus ointment that was first approved by the FDA in 2000. This prescription medication is used to treat patients older than two years of age who have moderate to severe atopic dermatitis, a form of eczema. There are two strengths of Protopic though only one is approved for pediatric use. Patients who must take this medication should use it on a short term basis and no longer than necessary in light of protopic causing cancer.

In addition to concerns about protopic causing cancer, there are certain patient populations for whom Protopic use is contraindicated. Women who are pregnant or breastfeeding should not use Protopic. Patients whose atopic dermatitis is infected should also not use this product. Patients with Netherton’s syndrome, a genetic condition marked by significant skin irritation, should also not use this topical ointment.

Information about protopic causing cancer was collected from animal studies, human case studies, and scientific knowledge about how this medication works. In animal studies, researchers found that those treated with protopic developed lymph node and skin cancer tumors at a faster rate than those not given protopic. Human case studies show protopic causing cancer in human subjects as well. The FDA has stated that it will take at least ten years of human clinical trials to determine the extent of protopic causing cancer risks.

In addition to protopic causing cancer, use of this prescription medication also carries other risks. Patients using protopic may experience common skin irritations including stinging, burning, itching, redness and soreness, headaches, and influenza-like symptoms. Protopic users are at an increased risk of developing some viral infections including chicken pox and shingles. Exposure to sunlight or tanning beds can also increase the chances of protopic causing cancer.

If you or a loved one has used protopic tacrolimus ointment, you may wish to speak with your health care professional about the risks of protopic causing cancer. Patients should only use this product exactly as directed by a doctor for the shortest duration of treatment possible. A doctor will inform you of the way to use the ointment in order to mitigate the risk of protopic causing cancer.

If you or a loved one has developed cancer while using protopic ointment, you may wish to explore your legal rights and options with regards to seeking compensation for your losses. A highly trained and experienced attorney can help to protect and maximize your legal interests in a case involving protopic causing cancer.

===================================================

3.)  PROTOPIC, side effects
====================================================
Source: Http://
www.medicalmalpractice.com/

1.) What is Protopic?
2.) What is eczema?
3.) Side Effects
4.) 2005 FDA Warning over Protopic Cancer
5.) 2006 Protopic Cancer BLACK BOX WARNING
6.) Injured by Protopic?

On January 19, 2006, the FDA announced the approval of a BLACK BOX WARNING for Protopic Ointment to warn of the serious risk of cancer posed by this topical prescription medication. Evidence shows that Protopic increases the risk of skin cancer and lymphomas. If you or a loved one has developed cancer or other serious side effects while using Protopic, please contact us at Oshman & Mirisola to learn more about your legal rights and options. You may be eligible to receive compensation for your losses and suffering.

1.) What is Protopic?

The FDA approved Protopic (tacrolimus ointment) in 2000. This topical ointment is used to treat moderate to severe atopic dermatitis, also known as eczema. Protopic is not intended for use in children under the age of two. Astellas Pharma, Inc. (formerly known as Fujisawa Healthcare) manufactures Protopic ointment. Due to known Protopic side effects, this medication should only be used for a short period of time. Protopic is not intended for long-term use.

Experts also warn that Protopic should only be used as a “second-line” treatment when other medications have not successfully treated a patient’s eczema. Protopic may also be recommended when other medications have caused significant side effects. Nonetheless, Protopic should only be prescribed as a last resort treatment of eczema.

2.) What is eczema?

Eczema, or atopic dermatitis, is one of the most common skin conditions experienced by infants and young children. Experts estimate that 10 to 15 percent of all children suffer from eczema. In the majority of cases, eczema is resolved by the time these children enter their teens. However, for some patients, treatments are necessary to treat eczema.

Eczema is characterized by chronically itchy, dry, red, and scaly skin. Because patients often have an overwhelming urge to scratch at infected areas, significant skin damage can result. Although the exact cause of eczema is unknown, many experts believe there is an allergic or immune component to the condition.

Protopic, and a similar drug called Elidel (marketed by Novartis AG), are approved to treat eczema. While the exact function of these topical drugs are not well understood, it is thought that Protopic and Elidel have various effects on the immune system.

3.) Protopic Side Effect Risks

Serious Protopic side effects can include:


VIRAL INFECTIONS Protopic can increase the risk of getting shingles, chicken pox, or other viral infections.
SKIN IRRITATION While Protopic is intended to relieve symptoms of skin irritation, this drug can also aggravate skin problems. Protopic side effects can include stinging, soreness, a burning sensation, or itchy skin.
FLU-LIKE SYMPTOMS Protopic can cause a patient to develop symptoms of the flu and headaches. This may be due to the drug’s effects on the immune system.
SKIN CANCER AND LYMPHOMA Protopic cancer is a serious risk associated with this medication.
 

4.) 2005 FDA Warning over Protopic Cancer

In March 2005, the FDA issued an advisory warning to inform consumers about the rare but serious risk of Protopic cancer. Based on information from animal studies, human case studies, and knowledge of the drug’s function, Protopic appears to increase the risk of developing skin cancer and lymph node cancer (lymphoma).

Studies also show that skin tumors developed faster in subjects, treated with Protopic, who have been exposed to light. Therefore, patients undergoing light therapy for their skin condition, other forms of phototherapy, or those with a lot of exposure to the sun, may be at an increased risk for Protopic cancer.

When the FDA advisory warning was issued, the FDA stated that it might take ten or more years to determine if Protopic is undeniably linked to cancer. They announced that further studies would be conducted to learn more about the serious risks of Protopic cancer.

5.) 2006 Protopic Cancer BLACK BOX WARNING

In January 2006, the FDA announced that a black box warning, the strictest warning short of a recall, would be added to Protopic labeling to warn of the serious risks of cancer. The agency also issued a Medication Guide to help ensure that patients are aware of the serious risks of Protopic cancer.

The Protopic black box warning also reiterates that Protopic should only be used as a second-line treatment in patients who have not received relief from other medications who do not have any risk factors for Protopic side effects. Protopic’s maker and the FDA state they will continue to evaluate Protopic safety to determine the exact causation between this drug and various forms of cancer.

6.) Injured by Protopic?

If you or a loved one has suffered serious Protopic side effects, please contact us to speak with a qualified attorney at Oshman & Mirisola about your legal rights and options. We are experienced in handling cases of a similar nature and are prepared to protect and maximize your legal interests. You may be eligible to seek compensation for your losses and suffering.

Contact Us 

 

Si Te ha gustado, Compartelo